Insight on Central Nervous System

Published within

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | » »|

Type Product title / description Pub Price
Report
Report

Treatment Algorithms: Multiple Sclerosis - Interferons remain the mainstay of multiple sclerosis treatment

Analysis of current treatment dynamics in multiple sclerosis. The report assesses the prescribing patterns, patient segmentation, and compliance rates across the seven major markets using Datamonitor’s primary physician research of 133 neurologists.

Published By Datamonitor
16 Mar 2012 $7600
Buy
Report
Report

R&D Trends: Alzheimer’s Disease – Pipeline growth undeterred by high-profile failures

Review of key trends in the development of new Alzheimer’s disease drugs across the seven major markets. Includes detailed analyses of clinical trial design, target product profile, innovative early-stage projects, and future treatment developments.

Published By Datamonitor
23 Mar 2012 $3800
Buy
Report
Report

Epidemiology: Parkinson’s Disease – Aging population drives up prevalence

Overview of Parkinson's disease, definition, and a review of epidemiology literature. This report provides in-depth analysis of patient populations, a 10-year prevalent case forecast, and key patient segments across the seven major markets.

Published By Datamonitor
04 Apr 2012 $5700
Buy
Report
Report

R&D Trends: Autism Spectrum Disorders – Pipeline growth reflects increasing interest in autism

This report reviews the key trends in the autism spectrum disorders pipeline. The analysis is intended to support R&D decision-making by evaluating the dynamics of the pipeline and hypothesizing future treatments of autism spectrum disorders.

Published By Datamonitor
16 Apr 2012 $3800
Buy
Report
Report

Case Study: Autism Spectrum Disorders – Public awareness and physician detailing will drive market growth

This report examines the opportunities and threats within the autism spectrum disorders (ASDs) market. The analysis is intended to support company strategy and decision-making by providing actionable recommendations in the current treatment pathway.

Published By Datamonitor
16 Apr 2012 $1900
Buy
Report
Report

Epidemiology: Breakthrough Cancer Pain – Explosion of pain due to increased cancer incidence

This module gives an overview of breakthrough cancer pain in the seven major markets. In this module, Datamonitor provides an estimate and a 10-year forecast of prevalent cancer patients with breakthrough cancer pain.

Published By Datamonitor
24 Apr 2012 $5700
Buy
Report
Report

Product Profiles: Autism Spectrum Disorders – Growing interest in underserved market

This report reviews current brands indicated for the treatment of autism spectrum disorders (ASDs) and key drugs in clinical development for the potential treatment of these conditions.

Published By Datamonitor
26 Apr 2012 $3800
Buy
Report
Report

Epidemiology: Chronic Lower Back Pain – Millions will continue to be out of work over the next decade

Overview of chronic low back pain definition and a review of epidemiology literature. This report provides in depth analysis of patient populations, a 10-year prevalent forecast, and key patient segments across the seven major markets.

Published By Datamonitor
08 May 2012 $5700
Buy
Report
Report

Epidemiology: Trigeminal Neuralgia – The disease is not as rare as previously thought

Overview of trigeminal neuralgia definition and review of epidemiology literature. This report provides in-depth analysis of patient populations, a 10-year incident and total prevalent forecast and key patient segments across the seven major markets.

Published By Datamonitor
14 May 2012 $5700
Buy
Report
Report

Treatment Algorithms: Schizophrenia – New antipsychotic launches underwhelm

Analysis of current treatment dynamics in schizophrenia. The report assesses patient diagnosis rates and uptake rates of approved treatments across the seven major markets using Datamonitor’s primary physician research of 140 psychiatrists.

Published By Datamonitor
15 May 2012 $7600
Buy

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | » »|

No help is available.